source
- Pregnancy hormone explored as possible guide for cardiovascular drug developmentThe STAT+ newsletter preview highlights a discussion about whether a hormone that regulates pregnancy could be leveraged to direct a new cardiovascular therapy. The piece also notes that researche…
- Industry and patient groups urge FDA to revise master protocol guidanceIndustry groups and patient advocacy organizations have written to the U.S. Food and Drug Administration asking for several revisions to its recently updated draft guidance on master protocols for…